Gene Mutations in Cushing’s Syndrome

2.

Albiger

NM

,

Regazzo

D

,

Rubin

B

,

Ferrara

AM

,

Rizzati

S

,

Taschin

E

, .

A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype

.

Endocrine

.

2017

;

55

:

959

–

68

.

3.

Alencar

GA

,

Lerario

AM

,

Nishi

MY

,

Mariani

BMde P

,

Almeida

MQ

,

Tremblay

J

, .

ARMC5 Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia

.

J Clin Endocrinol Metab

.

2014

;

99

:

E1501

–

9

.

4.

Antonini

SRR

,

Latronico

AC

,

Elias

LLK

,

Cukiert

A

,

Machado

HR

,

Liberman

B

, .

Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours

.

Clin Endocrinol (Oxf)

.

2002

;

57

:

657

–

62

.

5.

Assié

G

,

Libé

R

,

Espiard

S

,

Rizk-Rabin

M

,

Guimier

A

,

Luscap

W

, .

ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing’s Syndrome

.

N Engl J Med

.

2013

;

369

:

2105

–

14

.

6.

Avvakumov

GV

,

Walker

JR

,

Xue

S

,

Finerty

PJ

,

Mackenzie

F

,

Newman

EM

, .

Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8)

.

J Biol Chem

.

2006

;

281

:

38061

–

70

.

7.

Bassett

JH

,

Forbes

SA

,

Pannett

AA

,

Lloyd

SE

,

Christie

PT

,

Wooding

C

, .

Characterization of mutations in patients with multiple endocrine neoplasia type 1

.

Am J Hum Genet

.

1998

;

62

:

232

–

44

.

8.

Bathon

K

,

Weigand

I

,

Vanselow

JT

,

Ronchi

CL

,

Sbiera

S

,

Schlosser

A

, .

Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome

.

Endocrinology

.

2019

;

160

:

447

–

59

.

9.

Bentley

L

,

Esapa

CT

,

Nesbit

MA

,

Head

RA

,

Evans

H

,

Lath

D

, .

An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess

.

Endocrinology

.

2014

;

155

:

908

–

22

.

10.

Bertherat

J

,

Horvath

A

,

Groussin

L

,

Grabar

S

,

Boikos

S

,

Cazabat

L

, .

Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes

.

J Clin Endocrinol Metab

.

2009

;

94

:

2085

–

91

.

11.

Berthon

A

,

Faucz

FR

,

Espiard

S

,

Drougat

L

,

Bertherat

J

,

Stratakis

CA

.

Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function

.

Hum Mol Genet

.

2017

;

26

:

3495

–

507

.

12.

Beuschlein

F

,

Fassnacht

M

,

Assié

G

,

Calebiro

D

,

Stratakis

CA

,

Osswald

A

, .

Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome

.

N Engl J Med

.

2014

;

370

:

1019

–

28

.

13.

Bilodeau

S

,

Vallette-Kasic

S

,

Gauthier

Y

,

Figarella-Branger

D

,

Brue

T

,

Berthelet

F

, .

Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease

.

Genes Dev

.

2006

;

20

:

2871

–

86

.

14.

Bonnet

S

,

Gaujoux

S

,

Launay

P

,

Baudry

C

,

Chokri

I

,

Ragazzon

B

, .

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

.

J Clin Endocrinol Metab

.

2011

;

96

:

E419

–

426

.

15.

Bourdeau

I

,

Oble

S

,

Magne

F

,

Lévesque

I

,

Cáceres-Gorriti

KY

,

Nolet

S

, .

ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia

.

Eur J Endocrinol

.

2016

;

174

:

85

–

96

.

16.

Bourdeau

I

,

Parisien-La Salle

S

,

Lacroix

A

.

Adrenocortical hyperplasia: A multifaceted disease

.

Best Pract Res Clin Endocrinol Metab

.

2020

;

34

:

101386

.

17.

Brown

RJ

,

Kelly

MH

,

Collins

MT

.

Cushing syndrome in the McCune-Albright syndrome

.

J Clin Endocrinol Metab

.

2010

;

95

:

1508

–

15

.

18.

Calebiro

D

,

Hannawacker

A

,

Lyga

S

,

Bathon

K

,

Zabel

U

,

Ronchi

C

, .

PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit

.

Nat Commun

.

2014

;

5

:

5680

.

19.

Cao

Y

,

He

M

,

Gao

Z

,

Peng

Y

,

Li

Y

,

Li

L

, .

Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome

.

Science

.

2014

;

344

:

913

–

7

.

20.

Cavalcante

IP

,

Nishi

M

,

Zerbini

MCN

,

Almeida

MQ

,

Brondani

VB

,

Botelho

MLAA

, .

The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)

.

Mol Cell Endocrinol

.

2018

;

460

:

36

–

46

.

21.

Cawley

NX

,

Li

Z

,

Loh

YP

.

60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides

.

J Mol Endocrinol

.

2016

;

56

:

T77

–

97

.

22.

Cazabat

L

,

Bouligand

J

,

Salenave

S

,

Bernier

M

,

Gaillard

S

,

Parker

F

, .

Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients

.

J Clin Endocrinol Metab

.

2012

;

97

:

E663

–

70

.

23.

Chasseloup

F

,

Pankratz

N

,

Lane

J

,

Faucz

FR

,

Keil

MF

,

Chittiboina

P

, .

Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing’s Disease With or Without an MEN4 Phenotype

.

J Clin Endocrinol Metab

.

2020

;

105

:

1983

–

2005

.

24.

Chasseloup

F

,

Bourdeau

I

,

Tabarin

A

,

Regazzo

D

,

Dumontet

C

,

Ladurelle

N

, .

Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing’s syndrome: a multicentre, retrospective, cohort study

.

Lancet Diabetes Endocrinol

.

2021

;

9

:

813

–

24

.

25.

Chen

J

,

Jian

X

,

Deng

S

,

Ma

Z

,

Shou

X

,

Shen

Y

, .

Identification of recurrent USP48 and BRAF mutations in Cushing’s disease

.

Nat Commun

.

2018

;

9

:

3171

.

26.

Cheung

J

,

Ginter

C

,

Cassidy

M

,

Franklin

MC

,

Rudolph

MJ

,

Robine

N

, .

Structural insights into mis-regulation of protein kinase A in human tumors

.

Proc Natl Acad Sci U S A

.

2015

;

112

:

1374

–

9

.

27.

Ciato

D

,

Albani

A

.

Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets

.

Front Endocrinol (Lausanne)

.

2020

;

11

:

21

.

28.

Correa

R

,

Zilbermint

M

,

Berthon

A

,

Espiard

S

,

Batsis

M

,

Papadakis

GZ

, .

The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia

.

Eur J Endocrinol

.

2015

;

173

:

435

–

40

.

29.

Dahia

PL

,

Aguiar

RC

,

Honegger

J

,

Fahlbush

R

,

Jordan

S

,

Lowe

DG

, .

Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours

.

Oncogene

.

1998

;

16

:

69

–

76

.

30.

de Laat

JM

,

Dekkers

OM

,

Pieterman

CRC

,

Kluijfhout

WP

,

Hermus

AR

,

Pereira

AM

, .

Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)

.

J Clin Endocrinol Metab

.

2015

;

100

:

3288

–

96

.

31.

Du

L

,

Bergsneider

M

,

Mirsadraei

L

,

Young

SH

,

Jonker

JW

,

Downes

M

, .

Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease

.

Proc Natl Acad Sci U S A

.

2013

;

110

:

8555

–

60

.

32.

El Ghorayeb

N

,

Bourdeau

I

,

Lacroix

A

.

Multiple aberrant hormone receptors in Cushing's syndrome

.

Eur J Endocrinol

.

2015

;

173

:

M45

–

60

.

33.

Faucz

FR

,

Zilbermint

M

,

Lodish

MB

,

Szarek

E

,

Trivellin

G

,

Sinaii

N

, .

Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation

.

J Clin Endocrinol Metab

.

2014

;

99

:

E1113

–

9

.

34.

Fukuoka

H

,

Shichi

H

,

Yamamoto

M

,

Takahashi

Y

.

The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing's Disease

.

Int J Mol Sci

.

2020

;

21

:

9132

.

35.

Gatta-Cherifi

B

,

Chabre

O

,

Murat

A

,

Niccoli

P

,

Cardot-Bauters

C

,

Rohmer

V

, .

Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database

.

Eur J Endocrinol

.

2012

;

166

:

269

–

79

.

36.

Gaujoux

S

,

Tissier

F

,

Groussin

L

,

Libé

R

,

Ragazzon

B

,

Launay

P

, .

Wnt/beta-catenin and 3’,5’-cyclic adenosine 5’-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors

.

J Clin Endocrinol Metab

.

2008

;

93

:

4135

–

40

.

37.

Gaujoux

S

,

Pinson

S

,

Gimenez-Roqueplo

A-P

,

Amar

L

,

Ragazzon

B

,

Launay

P

, .

Inactivation of the APC Gene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers

.

Clin Cancer Res

.

2010

;

16

:

5133

–

41

.

38.

Georgitsi

M

,

Raitila

A

,

Karhu

A

,

Tuppurainen

K

,

Mäkinen

MJ

,

Vierimaa

O

, .

Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations

.

Proc Natl Acad Sci U S A

.

2007

;

104

:

4101

–

5

.

39.

Ghazi

AA

,

Dezfooli

AA

,

Mohamadi

F

,

Yousefi

SV

,

Amirbaigloo

A

,

Ghazi

S

, .

Cushing Syndrome Secondary to a Thymic Carcinoid Tumor Due to Multiple Endocrine Neoplasia Type 1

.

Endocr Pract

.

2011

;

17

:

e92

–

6

.

40.

Goh

G

,

Scholl

UI

,

Healy

JM

,

Choi

M

,

Prasad

ML

,

Nelson-Williams

C

, .

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors

.

Nat Genet

.

2014

;

46

:

613

–

7

.

41.

Groussin

L

,

Horvath

A

,

Jullian

E

,

Boikos

S

,

Rene-Corail

F

,

Lefebvre

H

, .

A PRKAR1A Mutation Associated with Primary Pigmented Nodular Adrenocortical Disease in 12 Kindreds

.

J Clin Endocrinol Metab

.

2006

;

91

:

1943

–

9

.

42.

Hernández-Ramírez

LC

,

Stratakis

CA

.

Genetics of Cushing’s syndrome

.

Endocrinol Metab Clin North Am

.

2018

;

47

:

275

–

97

.

43.

Hernández-Ramírez

LC

,

Gam

R

,

Valdés

N

,

Lodish

MB

,

Pankratz

N

,

Balsalobre

A

, .

Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease

.

Endocr Relat Cancer

.

2017a

;

24

:

379

–

92

.

44.

Hernández-Ramírez

LC

,

Trivellin

G

,

Stratakis

CA

.

Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants

.

Horm Metab Res

.

2017b

;

49

:

286

–

95

.

45.

Herrmann

LJM

,

Heinze

B

,

Fassnacht

M

,

Willenberg

HS

,

Quinkler

M

,

Reisch

N

, .

TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma

.

J Clin Endocrinol Metab

.

2012

;

97

:

E476

–

85

.

46.

Hillhouse

EW

,

Grammatopoulos

DK

.

The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology

.

Endocr Rev

.

2006

;

27

:

260

–

86

.

47.

Horvath

A

,

Giatzakis

C

,

Robinson-White

A

,

Boikos

S

,

Levine

E

,

Griffin

K

, .

Adrenal Hyperplasia and Adenomas Are Associated with Inhibition of Phosphodiesterase 11A in Carriers of PDE11A Sequence Variants That Are Frequent in the Population

.

Cancer Res

.

2006

;

66

:

11571

–

5

.

48.

Horvath

A

,

Mericq

V

,

Stratakis

CA

.

Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia

.

N Engl J Med

.

2008

;

358

:

750

–

2

.

49.

Huang

JR

,

Tan

GM

,

Li

Y

,

Shi

Z

.

The Emerging Role of Cables1 in Cancer and Other Diseases

.

Mol Pharmacol

.

2017

;

92

:

240

–

5

.

50.

Huizenga

NA

,

Koper

JW

,

De Lange

P

,

Pols

HA

,

Stolk

RP

,

Burger

H

, .

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo

.

J Clin Endocrinol Metab

.

1998

;

83

:

144

–

51

.

51.

Igreja

S

,

Chahal

HS

,

King

P

,

Bolger

GB

,

Srirangalingam

U

,

Guasti

L

, .

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

.

Hum Mutat

.

2010

;

31

:

950

–

60

.

52.

Juszczak

A

,

Morris

D

,

Grossman

A

.

Cushing’s Syndrome [Internet]

. In:

Feingold

KR

,

Anawalt

B

,

Boyce

A

,

Chrousos

G

,

de Herder

WW

,

Dhatariya

K

, , editors.

Endotext. South Dartmouth (MA)

MDText.com, Inc.

;

2000

. [cited 2022 Mar 10]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279088/.

53.

Kamilaris

CDC

,

Faucz

FR

,

Andriessen

VC

,

Nilubol

N

,

Lee

C-CR

,

Ahlman

MA

, .

First Somatic PRKAR1A Defect Associated With Mosaicism for Another PRKAR1A Mutation in a Patient With Cushing Syndrome

.

J Endocr Soc

.

2021

;

5

:

bvab007

.

54.

Kasturi

K

,

Fernandes

L

,

Quezado

M

,

Eid

M

,

Marcus

L

,

Chittiboina

P

, .

Cushing disease in a patient with multiple endocrine neoplasia type 2B

.

J Clin Transl Endocrinol Case Rep

.

2017

;

4

:

1

–

4

.

55.

Kawashima

S-T

,

Usui

T

,

Sano

T

,

Iogawa

H

,

Hagiwara

H

,

Tamanaha

T

, .

P53 gene mutation in an atypical corticotroph adenoma with Cushing’s disease

.

Clin Endocrinol (Oxf)

.

2009

;

70

:

656

–

7

.

56.

Lacroix

A

,

Feelders

RA

,

Stratakis

CA

,

Nieman

LK

.

Cushing's syndrome

.

Lancet

.

2015

;

386

:

913

–

27

.

57.

Lampichler

K

,

Ferrer

P

,

Vila

G

,

Lutz

MI

,

Wolf

F

,

Knosp

E

, .

The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation

.

Endocr Relat Cancer

.

2015

;

22

:

793

–

803

.

58.

Lemmens

I

,

Van de Ven

WJM

,

Kas

K

,

Zhang

CX

,

Giraud

S

,

Wautot

V

, .

Identification of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene

.

Hum Mol Genet

.

1997

;

6

:

1177

–

83

.

59.

Li

FP

,

Fraumeni

JF

,

Mulvihill

JJ

,

Blattner

WA

,

Dreyfus

MG

,

Tucker

MA

, .

A cancer family syndrome in twenty-four kindreds

.

Cancer Res

.

1988

;

48

:

5358

–

62

.

60.

Liu

N-A

,

Jiang

H

,

Ben-Shlomo

A

,

Wawrowsky

K

,

Fan

X-M

,

Lin

S

, .

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor

.

Proc Natl Acad Sci U S A

.

2011

;

108

:

8414

–

9

.

61.

Machens

A

,

Dralle

H

.

Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside

.

Mol Cell Endocrinol

.

2006

;

247

:

34

–

40

.

62.

Mathiesen

JS

,

Effraimidis

G

,

Rossing

M

,

Rasmussen

ÅK

,

Hoejberg

L

,

Bastholt

L

, .

Multiple endocrine neoplasia type 2: A review

.

Semin Cancer Biol

.

2022

;

79

:

163

–

79

.

63.

Matsuzaki

LN

,

Canto-Costa

MHS

,

Hauache

OM

.

Cushing’s disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene

.

Clin Endocrinol (Oxf)

.

2004

;

60

:

142

–

3

.

64.

Naziat

A

,

Karavitaki

N

,

Thakker

R

,

Ansorge

O

,

Sadler

G

,

Gleeson

F

, .

Confusing genes: a patient with MEN2A and Cushing’s disease

.

Clin Endocrinol (Oxf)

.

2013

;

78

:

966

–

8

.

65.

Nelakurti

DD

,

Pappula

AL

,

Rajasekaran

S

,

Miles

WO

,

Petreaca

RC

.

Comprehensive Analysis of MEN1 Mutations and Their Role in Cancer

.

Cancers (Basel)

.

2020

;

12

:

2616

.

66.

Ray

DW

,

Littlewood

AC

,

Clark

AJ

,

Davis

JR

,

White

A

.

Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function

.

J Clin Invest

.

1994

;

93

:

1625

–

30

.

67.

Reincke

M

,

Sbiera

S

,

Hayakawa

A

,

Theodoropoulou

M

,

Osswald

A

,

Beuschlein

F

, .

Mutations in the deubiquitinase gene USP8 cause Cushing’s disease

.

Nat Genet

.

2015

;

47

:

31

–

8

.

68.

Rix

M

,

Hertel

N

,

Nielsen

F

,

Jacobsen

B

,

Hoejberg

A

,

Brixen

K

, .

Cushing’s disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1

.

Eur J Endocrinol Eur Fed Endocr Soc

.

2005

;

151

:

709

–

15

.

69.

Roussel-Gervais

A

,

Couture

C

,

Langlais

D

,

Takayasu

S

,

Balsalobre

A

,

Rueda

BR

, .

The Cables1 Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease

.

J Clin Endocrinol Metab

.

2016

;

101

:

513

–

22

.

70.

Salpea

P

,

Horvath

A

,

London

E

,

Faucz

FR

,

Vetro

A

,

Levy

I

, .

Deletions of the PRKAR1A Locus at 17q24.2-q24.3 in Carney Complex: Genotype-Phenotype Correlations and Implications for Genetic Testing

.

J Clin Endocrinol Metab

.

2014

;

99

:

E183

–

E188

.

71.

Sato

Y

,

Maekawa

S

,

Ishii

R

,

Sanada

M

,

Morikawa

T

,

Shiraishi

Y

, .

Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome

.

Science

.

2014

;

344

:

917

–

20

.

72.

Sbiera

S

,

Kunz

M

,

Weigand

I

,

Deutschbein

T

,

Dandekar

T

,

Fassnacht

M

.

The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight

.

Cancers

.

2019

;

11

:

1761

.

73.

Seemann

N

,

Kuhn

D

,

Wrocklage

C

,

Keyvani

K

,

Hackl

W

,

Buchfelder

M

, .

CDKN2A/p16 inactivation is related to pituitary adenoma type and size

.

J Pathol

.

2001

;

193

:

491

–

7

.

74.

Simonds

WF

,

Varghese

S

,

Marx

SJ

,

Nieman

LK

.

Cushing's syndrome in multiple endocrine neoplasia type 1

.

Clin Endocrinol (Oxf)

.

2012

;

76

:

379

–

86

.

75.

Stratakis

CA

,

Kirschner

LS

.

Clinical and Genetic Analysis of Primary Bilateral Adrenal Diseases (Micro- and Macronodular Disease) Leading to Cushing Syndrome

.

Horm Metab Res

.

2007

;

30

:

456

–

63

.

76.

Stratakis

CA

,

Carney

JA

,

Lin

JP

,

Papanicolaou

DA

,

Karl

M

,

Kastner

DL

, .

Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2

.

J Clin Invest

.

1996

;

97

:

699

–

705

.

77.

Stratakis

CA

,

Tichomirowa

MA

,

Boikos

S

,

Azevedo

MF

,

Lodish

M

,

Martari

M

, .

The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes

.

Clin Genet

.

2010

;

78

:

457

–

63

.

78.

Tadjine

M

,

Lampron

A

,

Ouadi

L

,

Bourdeau

I

.

Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas

.

Clin Endocrinol (Oxf)

.

2008

;

68

:

264

–

70

.

79.

Tateno

T

,

Izumiyama

H

,

Doi

M

,

Yoshimoto

T

,

Shichiri

M

,

Inoshita

N

, .

Differential gene expression in ACTH -secreting and non-functioning pituitary tumors

.

Eur J Endocrinol

.

2007

;

157

:

717

–

24

.

80.

Theodoropoulou

M

,

Reincke

M

,

Fassnacht

M

,

Komada

M

.

Decoding the genetic basis of Cushing’s disease: USP8 in the spotlight

.

Eur J Endocrinol

.

2015

;

173

:

M73

–

M83

.

81.

Thiel

A

,

Reis

A-C

,

Haase

M

,

Goh

G

,

Schott

M

,

Willenberg

HS

, .

PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases

.

Eur J Endocrinol

.

2015

;

172

:

677

–

85

.

82.

Tissier

F

,

Cavard

C

,

Groussin

L

,

Perlemoine

K

,

Fumey

G

,

Hagneré

A-M

, .

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors

.

Cancer Res

.

2005

;

65

:

7622

–

7

.

83.

Treppiedi

D

,

Barbieri

AM

,

Di Muro

G

,

Marra

G

,

Mangili

F

,

Catalano

R

, .

Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant

.

Cancers

.

2021

;

13

:

4022

.

84.

Vassiliadi

DA

,

Tsagarakis

S

.

Diagnosis and management of primary bilateral macronodular adrenal hyperplasia

.

Endocr Relat Cancer

.

2019

;

26

:

R567

–

81

.

85.

Vergès

B

,

Boureille

F

,

Goudet

P

,

Murat

A

,

Beckers

A

,

Sassolas

G

, .

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study

.

J Clin Endocrinol Metab

.

2002

;

87

:

457

–

65

.

86.

Vezzosi

D

,

Libé

R

,

Baudry

C

,

Rizk-Rabin

M

,

Horvath

A

,

Levy

I

, .

Phosphodiesterase 11A (PDE11A) Gene Defects in Patients with ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH): Functional Variants May Contribute to Genetic Susceptibility of Bilateral Adrenal Tumors

.

J Clin Endocrinol Metab

.

2012

;

97

:

E2063

–

E2069

.

87.

Vierimaa

O

,

Georgitsi

M

,

Lehtonen

R

,

Vahteristo

P

,

Kokko

A

,

Raitila

A

, .

Pituitary adenoma predisposition caused by germline mutations in the AIP gene

.

Science

.

2006

;

312

:

1228

–

30

.

88.

Walker

C

,

Wang

Y

,

Olivieri

C

,

Karamafrooz

A

,

Casby

J

,

Bathon

K

, .

Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity

.

Sci Adv

.

2019

;

5

:

eaaw9298

.

89.

Walker

C

,

Wang

Y

,

Olivieri

C

,

s M

V

,

Gao

J

,

Bernlohr

DA

, .

Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing’s Syndrome Driving Mutations of Protein Kinase A

.

J Mol Biol

.

2021

;

433

:

167123

.

90.

Wermer

P

.

Genetic aspects of adenomatosis of endocrine glands

.

Am J Med

.

1954

;

16

:

363

–

71

.

91.

Young

J

,

Haissaguerre

M

,

Viera-Pinto

O

,

Chabre

O

,

Baudin

E

,

Tabarin

A

.

Management of endocrine disease: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion

.

Eur J Endocrinol

.

2020

;

182

:

R29

–

R58

.

92.

Zhang

X

,

Horwitz

GA

,

Heaney

AP

,

Nakashima

M

,

Prezant

TR

,

Bronstein

MD

, .

Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas

.

J Clin Endocrinol Metab

.

1999

;

84

:

761

–

7

.

93.

Zhang

D

,

Du

L

,

Heaney

AP

.

Testicular Receptor-4: Novel Regulator of Glucocorticoid Resistance

.

J Clin Endocrinol Metab

.

2016

;

101

:

3123

–

33

.